机器人辅助与视频辅助胸腔镜食管癌切除术的多中心随机临床试验(REVATE 试验)
REVATE 试验在亚洲 3 个中心随机纳入 212 例拟行微创 McKeown 食管切除术的食管鳞癌患者(分析 203 例:机器人组 103 例、视频辅助组 100 例),比较两种术式对左侧喉返神经旁淋巴结清扫的效果与安全性。机器人组左喉返神经旁淋巴结清扫成功率 88.3%,高于视频辅助组的 69%(P < 0.001),且术后 1 周及 6 个月左喉返神经麻痹发生率更低。
要点
- 机器人组左喉返神经旁淋巴结清扫成功率为 88.3%,高于视频辅助组的 69%。
- 术后 6 个月永久性喉返神经麻痹率机器人组 5.8%,视频辅助组 20%。
- 机器人组纵隔淋巴结清扫数目中位数 16 枚,多于视频辅助组的 14 枚。
核心结论
- 在食管鳞癌患者中,机器人辅助食管切除术的左侧喉返神经旁淋巴结清扫成功率高于视频辅助胸腔镜手术。
- 机器人组的短期和长期喉返神经损伤发生率均低于视频辅助组。
- 两组术后并发症发生率相当,且均无院内死亡。
研究设计与样本
- 多中心随机临床试验,按中心分层,纳入拟行微创 McKeown 食管切除术的食管鳞癌患者。
- 2018 年 6 月至 2022 年 3 月共随机 212 例,来自亚洲 3 个中心,203 例纳入分析(机器人组 103 例、视频辅助组 100 例)。
- 主要终点为左侧喉返神经旁淋巴结清扫成功率,定义为至少切除 1 枚淋巴结且神经损伤不持续超过 6 个月。
- 次要终点包括围手术期结局与肿瘤学结局,注册号 NCT03713749。
主要发现
- 左喉返神经旁淋巴结清扫成功率机器人组 88.3%、视频辅助组 69%(P < 0.001)。
- 病理证实的至少切除 1 枚淋巴结比例机器人组 94.2%、视频辅助组 86%(P = 0.051)。
- 术后 1 周左喉返神经麻痹发生率机器人组 20.4%、视频辅助组 34%(P = 0.029)。
- 术后 6 个月永久性喉返神经麻痹率机器人组 5.8%、视频辅助组 20%(P = 0.003)。
- 纵隔淋巴结清扫数目中位数机器人组 16 枚(i.q.r. 12–22)、视频辅助组 14 枚(10–20)(P = 0.035)。
关键数值与推荐
- 主要终点成功定义:至少切除 1 枚左喉返神经旁淋巴结,且不造成持续超过 6 个月的神经损伤。
- 左喉返神经旁淋巴结清扫成功率:机器人组 88.3% vs 视频辅助组 69%(P < 0.001)。
- 术后 6 个月永久性喉返神经麻痹率:5.8% vs 20%(P = 0.003)。
临床怎么用
- 对食管鳞癌行微创 McKeown 食管切除术时,机器人辅助有助于提高左喉返神经旁淋巴结清扫成功率。
- 机器人辅助可降低短期及永久性喉返神经麻痹风险,可能减少相关肺部并发症风险。
- 两组术后并发症率相当,术式选择可结合中心技术条件与患者情况个体化决定。
局限性
- 原文摘要未报告盲法、失访情况及长期肿瘤学随访结果,相关局限未在摘要中说明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgery for oesophageal squamous cell carcinoma involves dissecting lymph nodes along the recurrent laryngeal nerve. This is technically challenging and injury to the recurrent laryngeal nerve may lead to vocal cord palsy, which increases the risk of pulmonary complications. The aim of this study was to compare the efficacy and safety of robot-assisted oesophagectomy (RAO) versus video-assisted thoracoscopic oesophagectomy (VAO) for dissection of lymph nodes along the left RLN. METHODS: Patients with oesophageal squamous cell carcinoma who were scheduled for minimally invasive McKeown oesophagectomy were allocated randomly to RAO or VAO, stratified by centre. The primary endpoint was the success rate of left recurrent laryngeal nerve lymph node dissection. Success was defined as the removal of at least one lymph node without causing nerve damage lasting longer than 6 months. Secondary endpoints were perioperative and oncological outcomes. RESULTS: From June 2018 to March 2022, 212 patients from 3 centres in Asia were randomized, and 203 were included in the analysis (RAO group 103; VAO group 100). Successful left recurrent laryngeal nerve lymph node dissection was achieved in 88.3% of the RAO group and 69% of the VAO group (P < 0.001). The rate of removal of at least one lymph node according to pathology was 94.2% for the RAO and 86% for the VAO group (P = 0.051). At 1 week after surgery, the RAO group had a lower incidence of left recurrent laryngeal nerve palsy than the VAO group (20.4 versus 34%; P = 0.029); permanent recurrent laryngeal nerve palsy rates at 6 months were 5.8 and 20% respectively (P = 0.003). More mediastinal lymph nodes were dissected in the RAO group (median 16 (i.q.r. 12-22) versus 14 (10-20); P = 0.035). Postoperative complication rates were comparable between the two groups and there were no in-hospital deaths. CONCLUSION: In patients with oesophageal squamous cell carcinoma, RAO leads to more successful left recurrent laryngeal nerve lymph node dissection than VAO, including a lower rate of short- and long-term recurrent laryngeal nerve injury. Registration number: NCT03713749 (http://www.clinicaltrials.gov). Oesophageal cancer often requires complex surgery. Recently, minimally invasive techniques like robot- and video-assisted surgery have emerged to improve outcomes. This study compared robot- and video-assisted surgery for oesophageal cancer, focusing on removing lymph nodes near a critical nerve. Patients with a specific oesophageal cancer type were assigned randomly to robot- or video-assisted surgery at three Asian hospitals. Robot-assisted surgery had a higher success rate in removing lymph nodes near the important nerve without permanent damage. It also had shorter operating times, more lymph nodes removed, and faster drain removal after surgery. In summary, for oesophageal cancer surgery, the robotic approach may provide better lymph node removal and less nerve injury than video-assisted techniques.
引用
- Chao YK, Li Z, Jiang H, et al. Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial). Br J Surg. 2024. PMID: 38960881. doi:10.1093/bjs/znae143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。